← Back to feed

Imaging Biometrics Ltd

IBAI · Main Market · Health Care · mcap £2.5m today

All announcements

All RNS · 24 Key events · 22

01 Oct 26

Strengthening pipeline prominent US institutions

Q3 2026 Shareholder Update: strengthening pipeline of prominent US institutions
RNS 9800278 ↗
15 Sep 26

Adoption of Advanced Brain Tumor Imaging Platform

("Imaging Biometrics", the "Company" or, together with its subsidiaries, the "Group")
RNS 9771612 ↗
28 Aug 26

US Academic Medical Centre Adopts IB Clinic

("Imaging Biometrics", the "Company" or, together with its subsidiaries, the "Group")
RNS 9744393 ↗
29 Jul 26

Half-year Results

Imaging Biometrics Limited (the "Company" or the "Group")
RNS 9692236 ↗
14 Jul 26

Sub-division

Further to the announcements of 12 May and 3 June, the Company is pleased to confirm that the sub-division has completed with a resulting 246,709,789 ordinary shares of £0.005.
RNS 9667854 ↗
09 Jun 26

Publication of Phase 1 Clinical Trial

Publication of Phase 1 Clinical Trial of Oral Gallium Maltolate (GaM) in Recurrent Glioblastoma and Reopening of Expanded Access Programme
RNS 9607773 ↗
05 Jun 26

Commercialisation, Phase II Results & Revenue Path

IB Neuro™ Commercialisation Plan - ASCO 2026 Phase II Results and Strategic Revenue Pathway
RNS 9603095 ↗
03 Jun 26

AGM Statement and Business Update

Imaging Biometrics Limited (LSE: IBAI) is pleased to provide this update to shareholders ahead of its Annual General Meeting being held today.
RNS 9598337 ↗
13 May 26

Amendement To Notice Of Annual General Meeting

The Company notes an error to RNS 12 May 2026 (RNS Number: 0280E), that incorrectly stated that the ordinary shares of £0.01 will be sub-divided into one ordinary share of £0.0005.
RNS 9565161 ↗
08 May 26

KIRKSTALL AWARDED BBSRC/NC3Rs GRANT: GLIOBLASTOMA

KIRKSTALL AWARDED BBSRC/NC3Rs GRANT FOR GLIOBLASTOMA 'TUMOUR ON A CHIP' RESEARCH
RNS 9558153 ↗
30 Apr 26

Annual Report for the Year Ended 31 December 2025

Publication of Annual Report for the Year Ended 31 December 2025
RNS 9547557 ↗
19 Feb 26

Board Appointment

Imaging Biometrics Limited (LSE: IBAI) is pleased to announce the appointment of John Charles Richardson as a Non-Executive Director with effect from 1 March 2026 and will become a member of the remuneration and audit committees.
RNS 9438558 ↗
11 Feb 26

Update and IB Nimble Webinar – 27 February 2026

Imaging Biometrics Limited ('IBAI') comprises two subsidiary businesses, Imaging Biometrics LLC and Kirkstall Limited.
RNS 9424669 ↗
16 Jan 26

Strategic Direction Fueling Organic Growth

Imaging Biometrics, Ltd, (LSE: IBAI) is pleased to provide an update on its involvement in the development of gallium maltolate as well as its strategic priorities for 2026.
RNS 9357588 ↗
10 Dec 25

Expansion Global Distribution Agreement with GE

Imaging Biometrics Expands Global Distribution Agreement with GE HealthCare to Include FTB Express Maps and QSMetric™
RNS 9287603 ↗
26 Nov 25

Release of Next-Generation IB Clinic

Imaging Biometrics Announces Release of Next-Generation IB Clinic
RNS 9259230 ↗
24 Nov 25

Directorate Change

The Company announces that Dr Al Musella will step down from the Board of Directors with effect from 31 December 2025.
RNS 9253064 ↗
13 Nov 25

Fractional Tumor Burden Mapping Enhances GBM Trial

Imaging Biometrics' Fractional Tumor Burden Mapping Enhances GBM Trial
RNS 9231765 ↗
10 Nov 25

IB Announces Completion of Phase 1 Trial of GaM

Imaging Biometrics Announces Successful Completion of Phase 1 Trial of Gallium Maltolate in Recurrent Glioblastoma
RNS 9224230 ↗
16 Oct 25

Further Re: Purchase of interest in Kirkstall Ltd

Further Re: Purchase of interest in Kirkstall Limited
RNS 9174021 ↗
14 Oct 25

Purchase of Kirkstall and CLN - Correction

Purchase of Kirkstall Limited and CLN with Truetide plc - Correction
RNS 9170225 ↗
14 Oct 25

Purchase of Kirkstall and CLN with Truetide plc

Purchase of Kirkstall Limited and CLN with Truetide plc
RNS 9168712 ↗

Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.